These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 27151135)
1. Enhanced Solubility and Bioavailability of Naringenin via Liposomal Nanoformulation: Preparation and In Vitro and In Vivo Evaluations. Wang Y; Wang S; Firempong CK; Zhang H; Wang M; Zhang Y; Zhu Y; Yu J; Xu X AAPS PharmSciTech; 2017 Apr; 18(3):586-594. PubMed ID: 27151135 [TBL] [Abstract][Full Text] [Related]
2. Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats. Zhu Y; Wang M; Zhang J; Peng W; Firempong CK; Deng W; Wang Q; Wang S; Shi F; Yu J; Xu X; Zhang W Arch Pharm Res; 2015 Apr; 38(4):512-21. PubMed ID: 25231341 [TBL] [Abstract][Full Text] [Related]
3. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study. Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760 [TBL] [Abstract][Full Text] [Related]
4. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement. Gera S; Talluri S; Rangaraj N; Sampathi S AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300 [TBL] [Abstract][Full Text] [Related]
5. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J Drug Deliv; 2015; 22(4):552-61. PubMed ID: 24512268 [TBL] [Abstract][Full Text] [Related]
6. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
7. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability. Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System. Nekkanti V; Wang Z; Betageri GV AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913 [TBL] [Abstract][Full Text] [Related]
9. Chitosan Oligosaccharide Modified Bovine Serum Albumin Nanoparticles for Improving Oral Bioavailability of Naringenin. Fang R; Liao Y; Qiu H; Liu Y; Lin S; Chen H Curr Drug Deliv; 2024; 21(8):1142-1150. PubMed ID: 37464826 [TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, in vitro and in vivo studies of liposomal berberine using novel natural Fiber Interlaced Liposomal technology. Sharma VM; Valsaraj TV; Venkataramana Sudeep H; Raj A; Kodimule S; Jacob J Eur J Pharm Biopharm; 2024 Oct; 203():114431. PubMed ID: 39094668 [TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil. Al Asmari AK; Ullah Z; Tariq M; Fatani A Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457 [TBL] [Abstract][Full Text] [Related]
12. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Yen FL; Wu TH; Lin LT; Cham TM; Lin CC Pharm Res; 2009 Apr; 26(4):893-902. PubMed ID: 19034626 [TBL] [Abstract][Full Text] [Related]
13. Preparation and Characterization of Syringic Acid-Loaded TPGS Liposome with Enhanced Oral Bioavailability and In Vivo Antioxidant Efficiency. Liu Y; Sun C; Li W; Adu-Frimpong M; Wang Q; Yu J; Xu X AAPS PharmSciTech; 2019 Feb; 20(3):98. PubMed ID: 30719694 [TBL] [Abstract][Full Text] [Related]
14. Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability. Byeon JC; Lee SE; Kim TH; Ahn JB; Kim DH; Choi JS; Park JS Drug Deliv; 2019 Dec; 26(1):216-225. PubMed ID: 30843439 [TBL] [Abstract][Full Text] [Related]
15. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations. Sawant KK; Patel MH; Patel K Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349 [TBL] [Abstract][Full Text] [Related]
16. Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation. Wang X; Guan Q; Chen W; Hu X; Li L Drug Des Devel Ther; 2015; 9():1805-13. PubMed ID: 25848217 [TBL] [Abstract][Full Text] [Related]
17. Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol. Basavaraj S; Betageri GV Expert Opin Drug Deliv; 2014 Apr; 11(4):493-503. PubMed ID: 24456117 [TBL] [Abstract][Full Text] [Related]
18. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10. Shao Y; Yang L; Han HK Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680 [TBL] [Abstract][Full Text] [Related]
19. Novel self-nanomicellizing formulation based on Rebaudioside A: A potential nanoplatform for oral delivery of naringenin. Wang H; He Y; Hou Y; Geng Y; Wu X Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110926. PubMed ID: 32409076 [TBL] [Abstract][Full Text] [Related]
20. PLGA nanoparticles introduction into mitoxantrone-loaded ultrasound-responsive liposomes: In vitro and in vivo investigations. Xin Y; Qi Q; Mao Z; Zhan X Int J Pharm; 2017 Aug; 528(1-2):47-54. PubMed ID: 28559216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]